In addition to myocardial infarction, PSGL-1 is also known to be involved in the manifestation of coronary heart disease, which is defined as a cascade of coronary atherosclerotic events in which lipid and fibrous matrix become deposited on the walls of coronary arteries to form atheromatous plaques (46–48). Here, SELPLG is linked to coronary artery disorder.